Top Markets
Coin of the day
Manzo Pharmaceuticals, Inc. Manzo Pharmaceuticals, Inc.

Manzo Pharmaceuticals, Inc.

MNZO
Rang in Aktien #40587
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the... Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic. Headquartered in Milford, Pennsylvania, the organization was formerly known as Fortune Oil & Gas, Inc. before adopting its current name, Manzo Pharmaceuticals, Inc., in September 2014.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-12
Marktkapitalisierung
$115.95K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Manzo Pharmaceuticals, Inc. (MNZO)

Kategorie

Dividendenhistorie für Manzo Pharmaceuticals, Inc. (MNZO)
Manzo Pharmaceuticals, Inc. (Aktienkürzel: MNZO) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Manzo Pharmaceuticals, Inc. (MNZO) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber